Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:49 p.m.

    📋 Deciphera Pharmaceuticals, Inc. (DCPH) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:08:05

    Event Type: Financial Results

    Event Details:

    Deciphera Pharmaceuticals Inc (DCPH) Reports Q3 2022 Financial Results Deciphera Pharmaceuticals Inc (DCPH) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 1799
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 109698
      • Expected by Fourth Quarter 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 17.94K 18.66K $-716.00 -3.84%
    Property Equipment Net 7.35K 8.61K $-1.26K -14.60%
    Current Liabilities Accounts Payable 16.23K 13.13K $3.10K +23.60%
    Current Liabilities Operating Lease Liabilities 3.10K 2.87K $232.00 +8.08%
    Cost And Operating Expenses Selling General Administrative 32.83K 57.95K $-25.12K -43.35%
    Loss From Operations 70.51K 90.68K $-20.17K -22.24%
    Total Other Income Expense 81.00 727.00 $-646.00 -88.86%
    Net Loss 70.43K 89.95K $-19.52K -21.70%
    Net Loss Per Share 1.21 1.31 $-0.10 -7.63%
    Prepaid Expenses and Other Current Assets 18.66K 18.66K $0.00 +0.00%
    Property and Equipment, Net 8.61K 8.61K $0.00 +0.00%
    Accounts Payable 13.13K 13.13K $0.00 +0.00%
    Operating Lease Liabilities 2.87K 2.87K $0.00 +0.00%
    Revenue 22.05K 60.31K $-38.26K -63.44%
    Selling, General & Administrative 32.83K 57.95K $-25.12K -43.35%
    Loss from Operations 70.51K 90.68K $-20.17K -22.24%
    Other Income, Net 81.00 727.00 $-646.00 -88.86%
    Total Other Income/(Expense) 81.00 727.00 $-646.00 -88.86%
    Net Loss 70.43K 89.95K $-19.52K -21.70%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Deciphera Pharmaceuticals Inc
    • CIK: 0001654151
    • Ticker Symbol: DCPH
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories